FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

420686001: Product containing bendroflumethiazide and propranolol (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3503324015 Product containing bendroflumethiazide and propranolol (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3713421015 Bendroflumethiazide- and propranolol-containing product en Synonym Active Entire term case insensitive SNOMED CT core module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bendroflumethiazide and propranolol Is a Product containing bendroflumethiazide true Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and propranolol Is a Product containing propranolol true Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and propranolol Has active ingredient Propranolol true Inferred relationship Existential restriction modifier 1
Product containing bendroflumethiazide and propranolol Has active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier 2
Product containing bendroflumethiazide and propranolol Is a Propranolol+diuretic false Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and propranolol Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and propranolol Plays role Diuretic therapeutic role true Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and propranolol Is a Virtual therapeutic moiety false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule Is a False Product containing bendroflumethiazide and propranolol Inferred relationship Existential restriction modifier
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Is a False Product containing bendroflumethiazide and propranolol Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule Is a False Product containing bendroflumethiazide and propranolol Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form) Is a True Product containing bendroflumethiazide and propranolol Inferred relationship Existential restriction modifier
Propranolol + Bendroflumethiazide Is a True Product containing bendroflumethiazide and propranolol Inferred relationship Existential restriction modifier
Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules Is a False Product containing bendroflumethiazide and propranolol Inferred relationship Existential restriction modifier
Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules Is a False Product containing bendroflumethiazide and propranolol Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start